empty

Clinical

Asthma drug shortens at-home recovery from Covid-19

Early treatment with inhaled budesonide shortens recovery time among Covid-19 patients being treated in the community, PRINCIPLE has shown. 

New NICE guidance on chronic pain

People with chronic primary pain should be offered a range of treatments to help them manage their condition, says NICE in a new guideline.

Asthma exacerbation rates fall during pandemic

Fewer people with severe asthma attacks were admitted to hospital or seen by their GP during the Covid-19 pandemic.

Swallowable sponge could reduce need for endoscopies

In trials just one in 30 of the patients offered the Cytosponge were referred for an endoscopy.

Groundbreaking antipsychotic drug withdrawal paper released

Academics believe the paper is the first to outline how patients can reduce their intake and risk of relapse.

Vaccine side effects generally mild, MHRA confirms

Most reports relate to injection site reactions and generalised symptoms reflecting a normal immune response to the vaccine.

Vaccines 'highly effective' in reducing severe Covid-19 in older adults

First dose protection ranged between 57-61 per cent for Pfizer vaccine and between 60-73 per cent for the Oxford-AZ vaccine (ChAdOx1)

Possible link between Covid and psychiatric disorders

As many as one in eight who have had Covid-19 may be diagnosed with a psychiatric or neurological condition for the first time within six months.

Opioid prescribing varies widely across England

Opioid prescribing varies considerably across England and is especially marked in areas of high socio-economic deprivation, a study shows. 

Fatigue, insomnia and anxiety are long term consequences of Covid-19

Study in The Lancet looks at Covid patients six months after discharge.

Experimental RSV drug ‘promising’ says MHRA

The MHRA has granted a ‘promising innovative medicine’ designation to experimental RSV drug nirsevimab. 

Men especially vulnerable to Covid-19, study confirms

Men almost three times more likely to be admitted to intensive care with coronavirus, a new study confirms. 

Naturally acquired immunity to Covid lasts at least five months

Naturally acquired immunity provides at least 83 per cent protection against reinfection, SIREN study shows

New guideline for long Covid care

The guidelines look at symptom management, when to refer and how to follow up patients in the longer term. 

Erythromycin alert for patients with prolonged QT interval

Potential drug interaction between rivaroxaban and erythromycin resulting in increased risk of bleeding identified

Asthma significantly impacts mental wellbeing, report finds

Nearly half of adults with asthma also diagnosed with a psychological condition, according to a new survey. 

HRT: breast cancer risk depends on formulation and duration of use

The risk that women using hormone replacement therapy (HRT) will develop breast cancer depends on the formulation and duration of use, a new analysis suggests.

Pharmacist interventions prevent pregnancy after EHC

Pharmacist interventions result in a significant increase in effective use of a contraceptive pill following emergency hormonal contraception.

Use of hormonal contraceptives linked to reduced asthma risk

A study claims the use of hormonal contraceptives may reduce the risk of severe asthma in women.

Most side effects of statins down to 'nocebo effect'

Most of the side-effects people suffer after taking statins are due to their negative associations with the drug, researchers have found.  

Previous 1 2 3 4 5 ... 8 Next


This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Training Matters's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.